|
⚲
|
| Keyboard |
| 436 LP
✚
|
|
|---|---|
| CIK # | 0001844560 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001844560] | |
| 4 | [0001844560] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| 436 LP | |
| LENZ Therapeutics Inc | |
| Akkaraju Srinivas | |
| Samsara BioCapital LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
LENZ Therapeutics Inc GRPH
Common Stock
|
2021-06-29 | Buy | 15,000 | $17.00 | 255,000 |
|
LENZ Therapeutics Inc GRPH
Common Stock
|
2021-06-29 | Buy | 485,000 | $17.00 | 8,245,000 |
|
LENZ Therapeutics Inc GRPH
Common Stock
|
2021-06-29 | Conversion | 22,753 | ||
|
LENZ Therapeutics Inc GRPH
Common Stock
|
2021-06-29 | Conversion | 6,167,763 | ||
|
LENZ Therapeutics Inc GRPH
Common Stock
|
2021-06-29 | Conversion | 741,107 | ||
|
LENZ Therapeutics Inc GRPH
Series B Redeemable Convertible Preferred Stock · derivative
|
2021-06-29 | Conversion | 55,336 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Series A Redeemable Convertible Preferred Stock · derivative
|
2021-06-29 | Conversion | 15,000,000 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Series B Redeemable Convertible Preferred Stock · derivative
|
2021-06-29 | Conversion | 1,802,372 | $0.00 |